Cite
HARVARD Citation
Eratne, D. et al. (2022). Cerebrospinal fluid Alzheimer disease biomarkers for assessing cognitive and neuropsychiatric symptoms: Expanding the 'toolkit' in the psychiatrist's diagnostic armamentarium. Australian and New Zealand journal of psychiatry. pp. 865-866. [Online].